Publications To Date

    NANOSTRING PUBLICATIONS

    Filter Publications

    PAGE 1 OF 24 | DISPLAYING 1 - 15 OF 359 RESULTS

    Asleh K et al. Predictive biomarkers for adjuvant capecitabine benefit in early stage triple negative breast cancer in the FinXX clinical trial., , Clin Cancer Res, Jan 31, 2020

    Su J et al. Prognostic Molecular Classification of Appendiceal Mucinous Neoplasms Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy., , Ann Surg Oncol, Jan 24, 2020

    Wagener-Ryczek S et al. Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma., , Cancer Immunol Immunother, Jan 20, 2020

    Figueiredo CR et al. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development., , J Pathol, Jan 20, 2020

    Cabrita R et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma., , Nature, Jan 15, 2020

    Helmink BA et al. B cells and tertiary lymphoid structures promote immunotherapy response., , Nature, Jan 15, 2020

    Scortegagna M et al. Siah2 control of T-regulatory cells limits anti-tumor immunity., , Nat Commun, Jan 07, 2020

    Alves R et al. Flow cytometry and targeted immune transcriptomics identify distinct profiles in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors with or without interferon-alpha., , J Transl Med, Jan 03, 2020

    Cesano A et al., Status of Immune Oncology: Challenges and Opportunities., , Methods Mol Biol, Jan 01, 2020

    Das K et al., Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue., , Methods Mol Biol, Jan 01, 2020

    Cesano A et al., Status of Immune Oncology: Challenges and Opportunities., , Methods Mol Biol, Jan 01, 2020

    Beechem JM et al., High-Plex Spatially Resolved RNA and Protein Detection Using Digital Spatial Profiling: A Technology Designed for Immuno-oncology Biomarker Discovery and Translational Research., , Methods Mol Biol, Jan 01, 2020

    Leong WI et al., Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate innate immunity and drive potent T cell-mediated anti-tumor responses., , Oncotarget, Dec 31, 2019

    Rozeman EA et al., Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM)., , Melanoma Res, Dec 26, 2019

    Kargl J et al., Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC., , JCI Insight, Dec 19, 2019